Palatin Technologies, Inc. (PTN)Healthcare | Biotechnology | Monmouth Junction, United States | NasdaqCM
9.52 USD
-0.48
(-4.800%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 9.60 +0.08 (0.840%) ⇧ (July 13, 2026, 4:10 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:30 a.m. EDT
The immediate outlook is severely clouded by a massive 99% collapse in share price over the last decade, driven by four consecutive years of negative annual returns. While the company recently executed a capital raise and moved to the Nasdaq, the underlying business is hemorrhaging cash with negative free cash flow, negative operating margins, and a forward P/E that indicates expected losses. The statistical forecast model, which is designed to catch short-term noise, also leans slightly negative, reinforcing the bearish sentiment rather than offering a contrarian bounce. With no dividend to provide income and a balance sheet showing significant cash burn relative to its tiny market cap, there is no compelling case for a near-term recovery or a long-term hold. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.381872 |
| MSTL | 0.383131 |
| AutoARIMA | 0.390389 |
| AutoETS | 0.392773 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 8.28 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.421 |
| Excess Kurtosis | -0.81 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.706 |
| Revenue per Share | 6.277 |
| Market Cap | 16,938,698 |
| Trailing P/E | 95.20 |
| Forward P/E | -3.92 |
| Beta | -0.07 |
| Profit Margins | -48.50% |
| Website | https://palatin.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.53846157 |
| Address1 | 11 Deer Park Drive |
| Address2 | Suite 204 |
| All Time High | 128,125.0 |
| All Time Low | 2.0 |
| Ask | 10.5 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 32,110 |
| Average Daily Volume3 Month | 17,332 |
| Average Volume | 17,332 |
| Average Volume10Days | 32,110 |
| Beta | -0.07 |
| Bid | 0.0 |
| Bid Size | 200 |
| Book Value | 5.963 |
| City | Monmouth Junction |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.52 |
| Current Ratio | 5.041 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 10.04 |
| Day Low | 9.5 |
| Debt To Equity | 2.706 |
| Display Name | Palatin |
| Ebitda | -8,752,423 |
| Ebitda Margins | -0.67931 |
| Enterprise To Ebitda | -0.807 |
| Enterprise To Revenue | 0.548 |
| Enterprise Value | 7,065,940 |
| Eps Current Year | -2.99 |
| Eps Forward | -2.43 |
| Eps Trailing Twelve Months | 0.1 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.249 |
| Fifty Day Average Change | -4.728999 |
| Fifty Day Average Change Percent | -0.3318829 |
| Fifty Two Week Change Percent | 53.846157 |
| Fifty Two Week High | 31.0 |
| Fifty Two Week High Change | -21.48 |
| Fifty Two Week High Change Percent | -0.6929032 |
| Fifty Two Week Low | 5.0 |
| Fifty Two Week Low Change | 4.5200005 |
| Fifty Two Week Low Change Percent | 0.9040001 |
| Fifty Two Week Range | 5.0 - 31.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 876,922,200,000 |
| Float Shares | 1,384,205 |
| Forward Eps | -2.43 |
| Forward P E | -3.9176955 |
| Free Cashflow | -13,673,166 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 29 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0428 |
| Gross Profits | 551,402 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07888 |
| Held Percent Institutions | 0.55578 |
| Implied Shares Outstanding | 1,779,275 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-05-29 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,754,956,800 |
| Last Split Factor | 1:50 |
| Long Business Summary | Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey. |
| Long Name | Palatin Technologies, Inc. |
| Market | us_market |
| Market Cap | 16,938,698 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_32651 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -6,249,112 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 17,774,957 |
| Number Of Analyst Opinions | 3 |
| Open | 9.8801 |
| Operating Cashflow | -14,932,332 |
| Operating Margins | -0.40325 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.62 |
| Phone | 609 495 2200 |
| Post Market Change | 0.07999992 |
| Post Market Change Percent | 0.8403353 |
| Post Market Price | 9.6 |
| Post Market Time | 1,783,973,404 |
| Previous Close | 10.0 |
| Price Eps Current Year | -3.1839466 |
| Price Hint | 2 |
| Price To Book | 1.596512 |
| Price To Sales Trailing12 Months | 1.3146814 |
| Profit Margins | -0.48501998 |
| Quick Ratio | 4.861 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.47999954 |
| Regular Market Change Percent | -4.7999954 |
| Regular Market Day High | 10.04 |
| Regular Market Day Low | 9.5 |
| Regular Market Day Range | 9.5 - 10.04 |
| Regular Market Open | 9.8801 |
| Regular Market Previous Close | 10.0 |
| Regular Market Price | 9.52 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 8,496 |
| Return On Assets | -0.65259004 |
| Return On Equity | -2.9723902 |
| Revenue Per Share | 6.277 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,779,275 |
| Shares Percent Shares Out | 0.1026 |
| Shares Short | 182,616 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 183,059 |
| Short Name | Palatin Technologies, Inc. |
| Short Percent Of Float | 0.1079 |
| Short Ratio | 12.58 |
| Source Interval | 15 |
| State | NJ |
| Symbol | PTN |
| Target High Price | 60.0 |
| Target Low Price | 47.5 |
| Target Mean Price | 53.5 |
| Target Median Price | 53.0 |
| Total Cash | 10,159,494 |
| Total Cash Per Share | 5.71 |
| Total Debt | 286,662 |
| Total Revenue | 12,884,261 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.1 |
| Trailing P E | 95.200005 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 15.75175 |
| Two Hundred Day Average Change | -6.2317495 |
| Two Hundred Day Average Change Percent | -0.39562267 |
| Type Disp | Equity |
| Volume | 8,496 |
| Website | https://palatin.com |
| Zip | 8,512 |